Bajaj Finance, Biocon & more: Top stocks to buy on December 9 — Check list
JP Morgan maintains a neutral stance on Bajaj Finance, citing strategic growth plans and market share ambitions. Goldman Sachs also holds a neutral rating for Biocon, following its planned integration with Biocon Biologics. Kotak Institutional Equities initiates coverage on Tata Capital with an ‘add’ rating, anticipating strong loan growth.🕒 1 min read
JP Morgan maintains a neutral stance on Bajaj Finance, citing strategic growth plans and market share ambitions. Goldman Sachs also holds a neutral rating for Biocon, following its planned integration with Biocon Biologics. Kotak Institutional Equities initiates coverage on Tata Capital with an ‘add’ rating, anticipating strong loan growth.
Continue Reading
- Nepal Star Rohit Paudel Given LBW Despite Ball Hitting Gloves, Furious Reaction May Attract ICC Punishment
- Which City Is Known As The Samosa Capital Of India?
- Parliament Monsoon Session Day 12 Live Updates: PM Modi Likely To Be Felicitated By NDA MPs For Op Sindoor Success
-
Glenn McGrath ‘Throws Chair’ After Getting Surpassed By Nathan Lyon In Elite List – Video
-
Yogi Adityanath’s ‘Love And Land Jihad” Warning Evokes Sharp Akhilesh Yadav Retort
- Akasa completes fresh investment transaction of Rs 1,200 crore
- 5 Foods To Avoid If You Are Suffering From Constipation
- Karnataka 2nd PUC Result 2026 LIVE: Class 12th Result To Be Out Soon
-
I’m trying my best and managing my workload as much as possible: Shami
- India vs Ireland Live Score, 2nd T20I: Focus On Vaibhav Sooryavanshi As India Face Ireland In Must-Win Game
